Compare QNCX & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | BOOM |
|---|---|---|
| Founded | 2012 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 173.8M |
| IPO Year | 2019 | 1995 |
| Metric | QNCX | BOOM |
|---|---|---|
| Price | $0.10 | $5.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $10.00 | $8.50 |
| AVG Volume (30 Days) | ★ 134.5M | 386.3K |
| Earning Date | 05-19-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 89.02 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $609,840,000.00 |
| Revenue This Year | N/A | $0.72 |
| Revenue Next Year | N/A | $7.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.09 | $5.41 |
| 52 Week High | $4.55 | $9.20 |
| Indicator | QNCX | BOOM |
|---|---|---|
| Relative Strength Index (RSI) | 27.56 | 28.32 |
| Support Level | N/A | N/A |
| Resistance Level | $0.98 | $6.75 |
| Average True Range (ATR) | 0.02 | 0.42 |
| MACD | 0.10 | -0.23 |
| Stochastic Oscillator | 12.00 | 5.44 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.